Valuation: Illumina, Inc.

Market Cap 3.43TCr 3.05TCr 2.79TCr 2.54TCr 4.79TCr 3,23700Cr 4.92TCr 34TCr 13TCr 1,71400Cr 13TCr 13TCr 5,40900Cr P/E 2026 *
44.5x
P/E 2027 * 37.8x
Enterprise Value 3.42TCr 3.04TCr 2.79TCr 2.54TCr 4.78TCr 3,22900Cr 4.91TCr 33TCr 13TCr 1,71000Cr 13TCr 13TCr 5,39600Cr EV / Sales 2026 *
7.38x
EV / Sales 2027 * 6.69x
Free-Float
74.99%
Yield 2026 *
-
Yield 2027 * -
1 day-7.44%
1 week-27.99%
Current month-11.49%
1 month-28.88%
3 months+4.50%
6 months+50.19%
Current year+59.24%
1 week 205
Extreme 205
256.09
1 month 205
Extreme 205
309.34
Current year 112.65
Extreme 112.65
309.34
1 year 112.65
Extreme 112.65
309.34
3 years 68.7
Extreme 68.7
309.34
5 years 68.7
Extreme 68.7
428
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer 55 29/05/2025
Director TitleAgeSince
Director/Board Member 65 28/07/2016
Director/Board Member 66 01/01/2017
Director/Board Member 65 05/02/2019
Date Insider Type Main position Quantity % Market Cap. Importance
05/10/26 Tax

Chief Executive Officer

-1,303 0.0009%
30/09/26
Corvex Management LP
OtherCompany 0 0% -
30/09/26 Free

Director

113 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-7.37%-27.99%+70.59%+85.10% 3.43TCr
-3.41%-3.96%+19.99%+49.69% 26TCr
-3.39%-4.06%+7.14%+16.29% 17TCr
-3.87%+3.47%-15.36%+67.46% 17TCr
-3.46%+3.70%-55.24%-16.17% 6.64TCr
+0.39%+6.01%+20.86%+49.21% 5.73TCr
+0.33%+4.92%0.00%-5.40% 5.6TCr
-2.79%-4.97%+17.29%+60.09% 4.99TCr
-0.63%-0.39%+4.70%+57.60% 5.03TCr
-2.58%-5.20%+22.36%+80.50% 4.59TCr
Average -2.74%-0.20%+9.23%+44.44% 9.54TCr
Weighted average by Cap. -2.97%+1.48%+6.20%+42.89%

Financials

2026 *2027 *
Net sales 463.24Cr 412.8Cr 377.57Cr 343.87Cr 648.17Cr 44TCr 665.64Cr 4.54TCr 1.81TCr 23TCr 1.74TCr 1.7TCr 73TCr 495.17Cr 441.25Cr 403.6Cr 367.57Cr 692.85Cr 47TCr 711.52Cr 4.85TCr 1.94TCr 25TCr 1.86TCr 1.82TCr 78TCr
Net income 80Cr 71Cr 65Cr 59Cr 111.67Cr 7.54TCr 114.68Cr 781.48Cr 312.49Cr 3.99TCr 299.56Cr 293.13Cr 13TCr 92Cr 82Cr 75Cr 68Cr 128.73Cr 8.69TCr 132.19Cr 900.85Cr 360.22Cr 4.6TCr 345.32Cr 337.9Cr 15TCr
Net Debt -8.36Cr -7.45Cr -6.81Cr -6.2Cr -12Cr -789.71Cr -12Cr -82Cr -33Cr -418.23Cr -31Cr -31Cr -1.32TCr -110.29Cr -98Cr -90Cr -82Cr -154.31Cr -10TCr -158.47Cr -1.08TCr -431.83Cr -5.52TCr -413.96Cr -405.07Cr -17TCr
Projected Income Statement - Annual - Illumina, Inc.
Logo Illumina, Inc.
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows: - product sales (85.4%): tools and instruments for sequencing, genotyping, genetic expression, etc.; - sales of services (14.6%). Net sales are distributed geographically as follows: the United States (51.6%), Americas (3.8%), Europe (29.1%), Asia/Pacific/Middle East/Africa (9.9%) and China/Taiwan/Hong Kong (5.6%).
Employees
8,625
Date Price Change Volume
06/26/06 $208.92 -7.78% 32,22,233
04/26/04 $226.54 -4.90% 30,36,411
03/26/03 $238.21 +5.13% 22,32,175
02/26/02 $226.58 -3.99% 29,25,989
30/26/30 $235.99 -18.64% 53,90,386
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Illumina, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
226.54USD
Average target price
261.60USD
Spread / Average Target
+15.48%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Illumina, Inc.
  1. Stock Market
  2. Stocks
  3. ILMN Stock